Ellenbecker Investment Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
CWP
DADC
Ellenbecker Investment Group's PFE Position: Q2 2026 in Review
Ellenbecker Investment Group increased its Pfizer (PFE) stake by 4.4% in Q2 2026, buying an estimated $12.3K and bringing the position to 11,031 shares worth $266K. The position accounts for 0.03% of the portfolio, ranked #126.
Ellenbecker Investment Group first reported a position in PFE in Q3 2018 and has held it in 26 quarters since. The position peaked at $501K in Q4 2022. 1,105 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Ellenbecker Investment Group held 11,031 shares of Pfizer worth $266K as of Q2 2026.
- Ellenbecker Investment Group bought 469 Pfizer shares in Q2 2026, an estimated $12.3K.
- Pfizer made up 0.03% of Ellenbecker Investment Group's portfolio in Q2 2026, its #126 holding.
- Ellenbecker Investment Group first reported a position in Pfizer in Q3 2018 and has held it in 26 quarters since.
- Ellenbecker Investment Group's Pfizer position peaked at $501K in Q4 2022.
- 1,105 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Ellenbecker Investment Group's 13F filing for Q2 2026, filed 27 Jul 2026.